Schimmel Paul

Director at ATYR; Director at ALNY; Director at Sirtris Pharmaceuticals, Inc., and 1 more

Sold, on record
$16.7M
Dollars the filings state
Form 4 sales
15
Latest May 20, 2020
Form 144 notices
0
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
8
Plan not stated
0
No plan
7
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. May 20, 2020Plan not stated

    ATYR

    Sold 1.9% of their holdings

    $31k8,447 shares at $3.64

    Filed May 22, 2020Form 4

  2. Mar 13, 2018Unusual

    ALNY

    Sold 100% of their holdings

    $4.2M27,823 shares at $150.00

    Filed Mar 14, 2018Form 4

  3. Apr 21, 2015Unusual

    ALNY

    Sold 100% of their holdings

    $1.3M10,000 shares at $130.02

    Filed Apr 23, 2015Form 4

  4. Mar 19, 2015Unusual

    ALNY

    Sold 100% of their holdings

    $1.2M10,000 shares at $120.00

    Filed Mar 19, 2015Form 4

  5. Dec 8, 2014Unusual

    ALNY

    Sold 100% of their holdings

    $1.6M15,000 shares at $105.00

    Filed Dec 10, 2014Form 4

  6. Oct 28, 2014Unusual

    ALNY

    Sold 100% of their holdings

    $1.4M15,000 shares at $95.00

    Filed Oct 30, 2014Form 4

  7. Jan 13, 2014Unusual

    ALNY

    Sold 100% of their holdings

    $1.3M15,000 shares at $85.36

    Filed Jan 14, 2014Form 4

  8. Dec 20, 2013Unusual

    ALNY

    Sold 100% of their holdings

    $975k15,000 shares at $65.00

    Filed Dec 23, 2013Form 4

  9. Oct 22, 2013Plan not stated

    ALNY

    Sold 10.6% of their holdings

    $900k15,000 shares at $60.00

    Filed Oct 24, 2013Form 4

  10. Sep 10, 2009Plan not stated

    ALNY

    Sold 22.3% of their holdings

    $1M45,600 shares at $22.15

    Filed Sep 11, 2009Form 4

10 of 15

Every transaction

Every transaction on a Form 4 or Form 5 by Schimmel Paul
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
May 27, 2026May 28, 2026ATYRDirectorBought100,000$0.50$50k779,143SEC
May 11, 2026May 13, 2026ATYRDirectorAwardedStock Option (right to buy)50,00050,000SEC
Oct 9, 2025Oct 9, 2025ATYRDirectorBought1M$0.91$913k1.4MSEC
May 1, 2025May 2, 2025ATYRDirectorAwardedStock Option (right to buy)50,00050,000SEC
Jul 24, 2024Jul 24, 2024ATYRDirectorBought100,000$1.84$184k413,023SEC
May 22, 2024May 23, 2024ATYRDirectorAwardedStock Option (right to buy)24,00024,000SEC
May 17, 2023May 19, 2023ATYRDirectorAwardedStock Option (right to buy)12,00012,000SEC
May 10, 2023May 11, 2023ATYRDirectorBought200,000$2.25$450k313,023SEC
Apr 26, 2023Apr 28, 2023ATYRDirectorExercised or settledRestricted Stock Unit6,0000SEC
Apr 26, 2023Apr 28, 2023ATYRDirectorExercised options6,0008,890SEC
Apr 26, 2022Apr 28, 2022ATYRDirectorAwardedRestricted Stock Units6,0006,000SEC
Sep 20, 2021Sep 22, 2021ATYRDirectorBought250,000$8.00$2M252,890SEC
Sep 20, 2021Sep 22, 2021ATYRDirectorGift500,000679,143SEC
May 18, 2021May 20, 2021ATYRDirectorBought50,000$3.98$199k113,023SEC
Apr 28, 2021Apr 29, 2021ATYRDirectorAwardedStock Option (right to buy)1,4281,428SEC
May 20, 2020May 22, 2020ATYRDirectorSold8,447$3.64$31k429,143SEC
May 6, 2020May 8, 2020ATYRDirectorAwardedStock Option (right to buy)1,4281,428SEC
Feb 10, 2020Feb 11, 2020ATYRDirectorBought254,000$4.25$1.1M437,590SEC
Oct 4, 2019Oct 4, 2019FBRXDirectorAwardedStock Option (right to buy)7,5007,500SEC
Jul 1, 2019Jul 2, 2019ALNYDirectorAwardedStock Option (right to buy)9,0009,000SEC
May 29, 2019May 31, 2019FBRXDirectorAwardedStock option (right to buy)20,00020,000SEC
May 8, 2019May 10, 2019ATYRDirectorAwardedStock Option (right to buy)20,00020,000SEC
Apr 12, 2019Apr 16, 2019ATYRDirectorAwarded1.8M$0.54$998k2.6MSEC
Nov 26, 2018Nov 28, 2018ATYRDirectorBought147,225$0.54$80k882,302SEC
Sep 4, 2018Sep 5, 2018ATYRDirectorBought42,749$0.74$32k735,077SEC
Aug 30, 2018Aug 31, 2018ATYRDirectorBought164,411$0.74$122k692,328SEC
Jun 21, 2018Jun 25, 2018FBRXDirectorAwardedStock option (right to buy)20,00020,000SEC
Jun 20, 2018Jun 22, 2018ALNYDirectorAwardedStock Option (right to buy)9,0009,000SEC
May 18, 2018May 21, 2018ATYRDirectorBought150,000$1.00$150k527,917SEC
May 15, 2018May 17, 2018ATYRDirectorAwardedStock Option (right to buy)20,00020,000SEC
Mar 13, 2018Mar 14, 2018ALNYDirectorSold27,823$150.00$4.2M0SEC
Mar 13, 2018Mar 14, 2018ALNYDirectorExercised or settledStock Option (right to buy)27,8230SEC
Mar 13, 2018Mar 14, 2018ALNYDirectorExercised options27,823$49.24$1.4M27,823SEC
Aug 31, 2017Sep 5, 2017ATYRDirectorBoughtWarrant to Purchase Common Stock35,37635,376SEC
Aug 31, 2017Sep 5, 2017ATYRDirectorBought94,336$2.65$250k377,917SEC
Jun 2, 2017Jun 6, 2017ALNYDirectorAwardedStock Option (right to buy)11,25011,250SEC
May 9, 2017May 11, 2017ATYRDirectorAwardedStock Option (right to buy)20,00020,000SEC
Apr 19, 2017Apr 21, 2017FBRXDirectorBought10,000$10.00$100k13,623SEC
Apr 19, 2017Apr 21, 2017FBRXDirectorConvertedSeries H Preferred Stock240,3160SEC
Apr 19, 2017Apr 21, 2017FBRXDirectorConverted34,8273,623SEC
Apr 12, 2017Apr 12, 2017FBRXDirectorAwardedStock Option (right to buy)4,5284,528SEC
Dec 21, 2016Dec 22, 2016ATYRDirectorBought25,000$2.27$57k721,814SEC
Dec 16, 2016Dec 19, 2016ATYRDirectorBought50,000$2.48$124k696,814SEC
Sep 23, 2016Dec 19, 2016ATYRDirectorGift25,144646,814SEC
Jun 3, 2016Jun 7, 2016ALNYDirectorAwardedStock Option (right to buy)11,25011,250SEC
May 24, 2016May 26, 2016ATYRDirectorAwardedStock Option (right to buy)18,00018,000SEC
Apr 14, 2016Apr 15, 2016ATYRDirectorBought66,219$4.18$277k53,012SEC
Apr 13, 2016Apr 14, 2016ATYRDirectorBought9,835$3.85$38k249,962SEC
Apr 12, 2016Apr 13, 2016ATYRDirectorBought9,127$3.71$34k240,127SEC
Apr 11, 2016Apr 12, 2016ATYRDirectorBought32,659$3.57$117k220,231SEC
Page 1

Sales and notices (15)

Form 144 notices and Form 4 sales by Schimmel Paul
Source
May 20, 2020May 22, 2020ATYRDirectorForm 4 sale8,447$31k1.9%Plan not statedSEC
Mar 13, 2018Mar 14, 2018ALNYDirectorForm 4 sale27,823$4.2M100.0%UnusualSEC
Apr 21, 2015Apr 23, 2015ALNYDirectorForm 4 sale10,000$1.3M100.0%UnusualSEC
Mar 19, 2015Mar 19, 2015ALNYDirectorForm 4 sale10,000$1.2M100.0%UnusualSEC
Dec 8, 2014Dec 10, 2014ALNYDirectorForm 4 sale15,000$1.6M100.0%UnusualSEC
Oct 28, 2014Oct 30, 2014ALNYDirectorForm 4 sale15,000$1.4M100.0%UnusualSEC
Jan 13, 2014Jan 14, 2014ALNYDirectorForm 4 sale15,000$1.3M100.0%UnusualSEC
Dec 20, 2013Dec 23, 2013ALNYDirectorForm 4 sale15,000$975k100.0%UnusualSEC
Oct 22, 2013Oct 24, 2013ALNYDirectorForm 4 sale15,000$900k10.6%Plan not statedSEC
Sep 10, 2009Sep 11, 2009ALNYDirectorForm 4 sale45,600$1M22.3%Plan not statedSEC
Sep 4, 2009Sep 9, 2009ALNYDirectorForm 4 sale29,400$647k12.6%Plan not statedSEC
Dec 4, 2007Dec 4, 2007ALNYDirectorForm 4 sale7,192$229k10.3%Plan not statedSEC
Dec 3, 2007Dec 4, 2007ALNYDirectorForm 4 sale48,808$1.6M17.0%Plan not statedSEC
Nov 30, 2007Dec 4, 2007Sirtris Pharmaceuticals, Inc.DirectorForm 4 sale11,503$196k3.3%Plan not statedSEC
Mar 2, 2006Mar 3, 2006ALKERMES INCDirectorForm 4 sale5,000$130k1.4%Plan not statedSEC